Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma
The Hindu Business Line - Sep 29, 2026
This marks Anupam Rasayan’s third strategic inorganic transaction, as the Surat-based specialty chemicals maker expands into finished pharmaceutical formulations